Overexpression of Dicer in precursor lesions of lung adenocarcinoma.

Differential microRNA (miR) expression is described in non-small cell lung carcinoma. miR biogenesis requires a set of proteins collectively referred to as the miR machinery. In the proposed multistep carcinogenesis model, peripheral adenocarcinoma of the lung develops from noninvasive precursor lesions known as atypical adenomatous hyperplasia (AAH) and bronchioloalveolar carcinoma (BAC). The gene array analysis of BAC and adenocarcinoma showed a transient up-regulation of Dicer (a key effector protein for small interfering RNA and miR function) and PACT along with down-regulation of most genes encoding miR machinery proteins. Immunohistochemically, Dicer was up-regulated in AAH and BAC and down-regulated in areas of invasion and in advanced adenocarcinoma. A fraction of adenocarcinomas lose Dicer as a result of deletions at the Dicer locus. Expanded immunohistochemical and Western blot analysis showed higher Dicer level in squamous cell carcinoma (SCC) of the lung when compared with adenocarcinoma. Other proteins of the RNA-induced silencing complex (RISC; SND1, PACT, and FXR1) were also present at higher levels in a SCC cell line when compared with an adenocarcinoma cell line. In conclusion, the stoichiometry of miR machinery and RISC depends on histologic subtype of lung carcinoma, varies along the AAH-BAC-adenocarcinoma sequence, and might explain the observed abnormal miR profile in lung cancer. The status of the endogenous miR machinery in various histologic subtypes and stages of lung cancer may help to predict the toxicity of and susceptibility to future RNA interference-based therapy.

[1]  L. Chung,et al.  Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance. , 2002, Cancer research.

[2]  Y. Nishiwaki,et al.  Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. , 2000, Lung cancer.

[3]  F. Bray,et al.  International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising , 2005, International journal of cancer.

[4]  G. Obernosterer,et al.  Post-transcriptional regulation of microRNA expression. , 2006, RNA.

[5]  T. Hobman,et al.  ago1 and dcr1, two core components of the RNA interference pathway, functionally diverge from rdp1 in regulating cell cycle events in Schizosaccharomyces pombe. , 2003, Molecular biology of the cell.

[6]  K M Kerr.  Pulmonary preinvasive neoplasia. , 2001, Journal of clinical pathology.

[7]  K. Kerr,et al.  Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma , 2004, The Journal of pathology.

[8]  Michael T. McManus,et al.  Dicer function is essential for lung epithelium morphogenesis , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Benz,et al.  Rapid alteration of microRNA levels by histone deacetylase inhibition. , 2006, Cancer research.

[10]  Tara L. Naylor,et al.  microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Joel S Parker,et al.  Extensive post-transcriptional regulation of microRNAs and its implications for cancer. , 2006, Genes & development.

[12]  S. Dacic,et al.  Patterns of Allelic Loss of Synchronous Adenocarcinomas of the Lung , 2005, The American journal of surgical pathology.

[13]  B. Henderson.  Post-Transcriptional Regulation , 2002 .

[14]  S. Hammond,et al.  MicroRNAs as oncogenes. , 2006, Current opinion in genetics & development.

[15]  A. Nicholson,et al.  Molecular characterization of a mouse cDNA encoding Dicer, a ribonuclease III ortholog involved in RNA interference , 2002, Mammalian Genome.

[16]  Shuta Tomida,et al.  Reduced expression of Dicer associated with poor prognosis in lung cancer patients , 2005, Cancer science.

[17]  Adriana L. Gonzalez,et al.  Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. , 2006, Cancer research.

[18]  J. Hunt,et al.  Analysis of Allelic Loss as an Adjuvant Tool in Evaluation of Malignancy in Uterine Smooth Muscle Tumors , 2006, The American journal of surgical pathology.

[19]  M. Roh,et al.  Expression of double‐stranded RNA‐activated protein kinase in small‐size peripheral adenocarcinoma of the lung , 2005, Pathology international.

[20]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[21]  V. Kim,et al.  The role of PACT in the RNA silencing pathway , 2006, The EMBO journal.

[22]  C. Croce,et al.  MicroRNA-cancer connection: the beginning of a new tale. , 2006, Cancer research.

[23]  Theresa A. Storm,et al.  Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways , 2006, Nature.

[24]  Rajiv Dhir,et al.  Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. , 2006, The American journal of pathology.